Table 4 Nonrelapse related causes of... | American Society of Hematology

Table 4

Nonrelapse related causes of death for patients treated with ¹³¹I-BC8/FLU/TBI

Fatal toxicity	AML (n = 28)		Secondary AML (n = 19)	MDS* (n = 11)	All patients (n = 58)
Fatal toxicity	REM	REF/REL	Secondary AML (n = 19)	MDS* (n = 11)	All patients (n = 58)
Infection, n	1	3	4	3	11
Pulmonary, n†	0	2	2	1	4
GVHD, n	0	0	0	1	1
CNS, n	0	0	1	0	1

Fatal toxicity	AML (n = 28)		Secondary AML (n = 19)	MDS* (n = 11)	All patients (n = 58)
Fatal toxicity	REM	REF/REL	Secondary AML (n = 19)	MDS* (n = 11)	All patients (n = 58)
Infection, n	1	3	4	3	11
Pulmonary, n†	0	2	2	1	4
GVHD, n	0	0	0	1	1
CNS, n	0	0	1	0	1

Total 100-day TRM (12 %).

REM indicates remission; REF/REL, refractory/relapsed; CNS, central nervous system.

MDS includes refractory anemia with excess of blasts and chronic myelomonocytic leukemia.

Pulmonary toxicity indicates noninfectious pneumonitis.